Restriction of FODMAP in the management of bloating in irritable bowel syndrome.
Irritable bowel syndrome (IBS) is a common functional bowel disorder. Up to 96% of IBS patients experience bloating, resulting in poor response to conventional therapies and high consultation rates. Many IBS patients report that food triggers symptoms, particularly diets with poorly absorbed, short-chain carbohydrates, and restrict intake of certain foods to control their symptoms. IBS patients are especially susceptible to an attack due to visceral hypersensitivity. An emerging therapeutic strategy excludes fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) from the diet. There is evidence supporting the efficacy of a low FODMAP diet in improving symptoms of bloating in IBS patients. Individualised, structured dietary guidance may benefit those with persistent troublesome symptoms despite traditional therapies. In view of the multifactorial aetiology of the condition, it is probably best to use a multipronged approach, involving combination therapies, to address bloating in IBS patients.
Division of Primary Care, Raffles Medical Group, Singapore.|Division of Family Medicine, Department of Medicine, University Medicine Cluster, National University Hospital System, Singapore.|Duke-NUS Graduate Medical School, National University of Singapore, Singapore.
Wei Mon
WM
Wong
D004032:Diet; D004187:Disaccharides; D005285:Fermentation; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000178:diet therapy* / Q000523:psychology; D009005:Monosaccharides; D018673:Nutrition Policy; D009844:Oligosaccharides; D011108:Polymers; D011788:Quality of Life; D012720:Severity of Illness Index
D004187:Disaccharides; D009005:Monosaccharides; D009844:Oligosaccharides; D011108:Polymers; C024617:polyol
FODMAPs; bloating; irritable bowel syndrome; low FODMAP diet
Clin Nutr. 2006 Oct;25(5):824-31
16410032
J Hum Nutr Diet. 2015 Dec;28(6):687-96
25871564
Am J Gastroenterol. 2008 May;103(5):1241-8
18422817
Gut. 2000 Nov;47 Suppl 2:ii1-19
11053260
Gastroenterol Hepatol (N Y). 2013 Jan;9(1):28-30
24707231
Isr Med Assoc J. 2000 Aug;2(8):583-7
10979349
Gut. 1998 May;42(5):690-5
9659166
J Gastroenterol Hepatol. 2010 Aug;25(8):1366-73
20659225
Gastroenterology. 2014 Jan;146(1):67-75.e5
24076059
Am J Gastroenterol. 2000 Jan;95(1):157-65
10638576
Curr Gastroenterol Rep. 2014 Jan;16(1):370
24357350
Eur J Clin Nutr. 2006 May;60(5):667-72
16391571
Aliment Pharmacol Ther. 1997 Apr;11(2):395-402
9146781
Eur J Nutr. 2016 Apr;55(3):897-906
25982757
BMJ. 2005 May 7;330(7499):1049
15817527
Am J Gastroenterol. 2009 Jan;104 Suppl 1:S1-35
19521341
J Hum Nutr Diet. 2014 Apr;27 Suppl 2:36-47
23659729
J Hum Nutr Diet. 2011 Oct;24(5):487-95
21615553
Gut. 1999 Sep;45 Suppl 2:II43-7
10457044
Aliment Pharmacol Ther. 2015 Jun;41(12):1256-70
25903636
J Gastroenterol Hepatol. 2010 Jul;25(7):1189-205
20594245
Dig Dis Sci. 2000 Jun;45(6):1166-71
10877233
Gastroenterol Hepatol (N Y). 2014 Sep;10(9):561-71
27551250
J Nutr. 2012 Aug;142(8):1510-8
22739368
World J Gastroenterol. 2014 Jun 7;20(21):6680-4
24914395
J Hum Nutr Diet. 2012 Jun;25(3):260-74
22489905
Am J Gastroenterol. 2013 May;108(5):634-41
23644955
Am Fam Physician. 2004 Feb 1;69(3):548-56
14971837
Am J Gastroenterol. 2007 Sep;102(9):1972-82
17488254
Am J Gastroenterol. 2006 Feb;101(2):326-33
16454838
World J Gastroenterol. 2014 Nov 21;20(43):16215-26
25473176
N Engl J Med. 2003 Nov 27;349(22):2136-46
14645642
Gastroenterol Hepatol. 2015 Mar;38(3):113-22
25458546
Mol Med Rep. 2012 Jun;5(6):1382-90
22446969
Mol Med Rep. 2013 Sep;8(3):845-52
23820783
Control Clin Trials. 1996 Feb;17(1):1-12
8721797
Int J Clin Pract. 2013 Sep;67(9):895-903
23701141
Therap Adv Gastroenterol. 2012 Jul;5(4):261-8
22778791
J Gastroenterol Hepatol. 2016 Jan;31(1):45-55
25819140
Clin Gastroenterol Hepatol. 2008 Jul;6(7):765-71
18456565
Gastroenterology. 2006 Apr;130(5):1480-91
16678561
BMJ. 2015 Feb 25;350:h701
25716701
J Am Diet Assoc. 2009 Jul;109(7):1204-14
19559137